HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Schöffski Selected Research

Erlotinib Hydrochloride (CP 358,774)

2/2015A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Schöffski Research Topics

Disease

25Neoplasms (Cancer)
01/2023 - 11/2003
13Sarcoma (Soft Tissue Sarcoma)
01/2021 - 01/2006
9Renal Cell Carcinoma (Grawitz Tumor)
11/2015 - 08/2006
8Fatigue
01/2018 - 01/2000
5Disease Progression
01/2023 - 04/2002
5Neoplasm Metastasis (Metastasis)
11/2015 - 04/2001
5Colorectal Neoplasms (Colorectal Cancer)
04/2008 - 02/2002
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2003 - 04/2002
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2023 - 10/2010
3Nausea
01/2018 - 04/2008
3Breast Neoplasms (Breast Cancer)
01/2018 - 05/2011
3Leiomyosarcoma
10/2013 - 04/2007
3Testicular Neoplasms (Testicular Cancer)
11/2003 - 04/2002
2Clear Cell Sarcoma
01/2019 - 12/2017
2Hypertension (High Blood Pressure)
01/2017 - 11/2015
2Melanoma (Melanoma, Malignant)
06/2011 - 01/2005
2Diarrhea
04/2008 - 03/2006
2Neutropenia
01/2006 - 04/2002
2Liver Diseases (Liver Disease)
03/2004 - 10/2001
2Xerostomia
06/2000 - 01/2000
1Liposarcoma
04/2020
1Alveolar Soft Part Sarcoma
01/2018
1Clinical Deterioration
01/2018
1Vomiting
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
11/2017
1medullary Thyroid cancer
11/2017
1Syncope (Fainting)
01/2017
1Edema (Dropsy)
01/2017
1Kaposi Sarcoma (Kaposi's Sarcoma)
04/2015
1Infections
04/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015
1Carcinoma (Carcinomatosis)
02/2015
1Glioma (Gliomas)
02/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015
1Synovial Sarcoma (Synovioma)
10/2013
1Rhabdomyosarcoma
10/2013
1Osteonecrosis (Kienbock's Disease)
11/2012

Drug/Important Bio-Agent (IBA)

7Sunitinib (Sutent)FDA Link
06/2015 - 08/2008
4Imatinib Mesylate (Gleevec)FDA Link
01/2023 - 08/2008
4pazopanibFDA Link
01/2018 - 11/2015
4TrabectedinIBA
01/2018 - 01/2006
4Tyrosine Kinase InhibitorsIBA
07/2016 - 08/2006
4Fluorouracil (Carac)FDA LinkGeneric
06/2013 - 04/2001
4Cisplatin (Platino)FDA LinkGeneric
01/2011 - 12/2000
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 04/2002
3CrizotinibIBA
01/2019 - 12/2017
3IfosfamideFDA LinkGeneric
01/2018 - 11/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 01/2011
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2015 - 01/2011
3Viscum ribosome inactivating proteinIBA
02/2015 - 12/2004
3Transaminases (Aminotransferases)IBA
12/2011 - 12/2004
3Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2008 - 04/2001
2Phosphotransferases (Kinase)IBA
11/2020 - 01/2015
2Monoclonal AntibodiesIBA
01/2017 - 10/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 11/2015
2Biomarkers (Surrogate Marker)IBA
11/2015 - 01/2015
2EverolimusFDA Link
04/2015 - 10/2010
2Docetaxel (Taxotere)FDA Link
06/2013 - 12/2000
2Cytotoxins (Cytolysins)IBA
09/2012 - 04/2001
2Alkaline PhosphataseIBA
12/2011 - 12/2004
2Topoisomerase I InhibitorsIBA
04/2007 - 04/2002
2Leucovorin (Folinic Acid)FDA Link
03/2006 - 10/2003
2Irinotecan (Camptosar)FDA LinkGeneric
03/2006 - 04/2001
2mistletoe lectin IIBA
07/2005 - 12/2004
2Paclitaxel (Taxol)FDA LinkGeneric
04/2002 - 10/2001
2Bendamustine HydrochlorideFDA Link
06/2000 - 01/2000
1avapritinibIBA
01/2023
1Adenosine Triphosphate (ATP)IBA
01/2023
1regorafenibIBA
01/2023
1Circulating Tumor DNAIBA
01/2023
1TropomyosinIBA
11/2020
1tyrosine receptor (receptor, tyrosine)IBA
11/2020
1BI-907828IBA
04/2020
1Proteins (Proteins, Gene)FDA Link
04/2020
1Transcription Factors (Transcription Factor)IBA
01/2018
1cabozantinibIBA
11/2017
1olaratumabIBA
01/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2015
1Terbinafine (Lamisil)FDA LinkGeneric
04/2015
1danusertibIBA
03/2015
1Aurora KinasesIBA
03/2015
1liposomal doxorubicin (Doxil)FDA Link
02/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2015
1BI 6727IBA
01/2015
1Immunoglobulin G (IgG)IBA
10/2013
1cixutumumabIBA
10/2013
1Immunoglobulins (Immunoglobulin)IBA
10/2013
1MicroRNAs (MicroRNA)IBA
09/2013
1Epirubicin (Ellence)FDA LinkGeneric
06/2013
1AfatinibIBA
06/2013
1multidrug resistance-associated protein 1IBA
06/2013
1Sorafenib (BAY 43-9006)FDA Link
11/2012
1Diphosphonates (Bisphosphonates)IBA
11/2012

Therapy/Procedure

11Drug Therapy (Chemotherapy)
01/2018 - 10/2001
9Therapeutics
11/2020 - 11/2002
2Adjuvant Chemotherapy
01/2018 - 06/2013
2Salvage Therapy
02/2013 - 04/2003
2Intravenous Infusions
12/2011 - 04/2004
1Kidney Transplantation
04/2015
1Radiotherapy
02/2015